Design Solution · Lighting
Design Solution · Dream about it
Rooftop sky-imaging + radiometry drives automated shades, tunable LEDs, and smart glass to deliver circadian light doses.
The system addresses the gap between static building envelope design and occupant circadian health by continuously measuring solar spectral conditions and cloud cover via rooftop sensors, then modulating integrated shade zones, LED colour temperature, and electrochromic glazing to maintain target melanopic lux and phase-shift timing. The shade-automation core (SolarTrac) is commercially deployed in shade control; full closed-loop circadian orchestration across shading, lighting, and glazing remains largely patent-described without published field-trial validation.
This system addresses the gap between static building envelope design and occupant circadian health by using rooftop spectral sensors and sky imaging to continuously modulate shading zones, tunable LED colour temperature, and electrochromic glazing in a closed feedback loop targeting melanopic lux and phase-shift timing — moving beyond fixed lighting schedules to real-time solar-condition response. The shade automation core (SolarTrac) is commercially deployed and provides a credible foundation; the three-way closed-loop circadian orchestration across shading, lighting, and glazing is where the record becomes substantially patent-described rather than field-validated, with no published circadian performance data from real building deployments. For a design team evaluating this, the site feasibility constraint is immediate: rooftop sensor placement requires clear sky access, which excludes urban canyon, heavily shaded, and retrofit-constrained sites before the cost conversation even begins. Three-way system coordination is inherently fragile — miscalibration in any one domain (sensor degradation, glazing opacity lag, LED colour drift) degrades the whole-system intent, and the ongoing recalibration and maintenance obligation is real. The clinical efficacy question also remains open: melanopic lux targeting in controlled laboratory settings does not automatically translate to occupant health outcomes in real buildings with diverse chronotypes, shift work patterns, and manual-override behaviour. A specifier designing a workplace where occupant wellbeing is a primary brief objective and all three system components are already in scope has a legitimate reason to explore this further; as a retrofit proposition or on cost-sensitive buildings, the capital intensity and unvalidated field performance make it premature.
Shade automation (SolarTrac core) is real, shipping, and specified in commercial projects — this layer is well-evidenced. The circadian LED tuning + electrochromic glazing control loop is described in the patent family (priority 2004, granted 2020, assignee MechoShade Systems LLC) but independent deployment evidence is sparse: no peer-reviewed field trials, no published occupant outcome studies, no third-party performance validation. Trade press mentions SolarTrac v4.0 as a product, but no case studies cite measured melanopic dose or sleep/alertness results. Patent claims are technically coherent but unvalidated in real buildings. Risk of overclaim on circadian efficacy.
#circadian_health #sky_imaging #solar_spectral #automated_shading #led_tuning #smart_glass #melanopic_lux #multi_domain_control